MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells. (2013)

First Author: Falck Miniotis M
Attributed to:  Multimodality Techniques for Cancer Diagnosis and Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-12-1969

PubMed Identifier: 23639941

Publication URI: http://europepmc.org/abstract/MED/23639941

Type: Journal Article/Review

Volume: 73

Parent Publication: Cancer research

Issue: 13

ISSN: 0008-5472